# The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

> **NCT01471184** · NA · COMPLETED · sponsor: **Bitop AG** · enrollment: 46 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergic Conjunctivitis

## Interventions

- **DEVICE:** Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01471184
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471184, "The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01471184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*